在低资源的紧急环境中管理儿科疼痛:障碍,进步和未来方向
Mohammed Alaswad1, Eslam Abady2, Elsayed S Moubarak3
1University of Hama, Syria.
Sage open pediatrics
|March 2, 2026
概括
在低收入和中等收入国家 (LMICs) 的儿科疼痛往往在急诊室 (EDs) 治疗不足. 本综述涵盖了改善LMICED儿童疼痛管理的既定和创新策略.
科学领域:
- 紧急医疗 紧急医疗
- 儿科 儿科 儿科
- 全球健康 全球健康
背景情况:
- 儿科疼痛在急诊室 (ED) 常常被忽视和管理不当,特别是在低收入和中等收入国家 (LMICs).
- 这种管理不足导致儿童遭受重大身体和心理伤害.
研究的目的:
- 综合当前关于LMIC紧急设置中的儿科疼痛管理的证据.
- 突出这一领域的既定实践和新兴创新.
主要方法:
- 这项研究是对LMIC紧急设置中儿科疼痛管理现有文献的叙事性审查.
- 它检查了药理和非药理干预措施,以及新的技术和基于劳动力的解决方案.
主要成果:
- 已建立的方法包括止痛药 (乙氨基,NSAID,阿片类药物) 和非药物方法 (分心,引导图像,父母参与).
- 在LMICs的实施障碍包括有限的提供者培训,对止痛药的限制和文化误解.
- 新兴创新包括任务转移,数字/人工智能疼痛评估工具和社区干预.
结论:
- 改善LMICs的儿科疼痛护理需要一个多方面的战略.
- 这包括文化适应的工具,平等获得止痛药,可扩展的非药物干预,以及技术支持的劳动力发展.
相关概念视频
Analgesia and Pain Management
2.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.4K
Pharmaceutical Poisoning: Potential Scenarios
47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Pharmacokinetics in Pediatric Patients: Drug Excretion
340
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Pharmacokinetics in Pediatric Patients: Drug Distribution
388
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.3K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
411
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
411


